R. Singh

Statistics

Publications

Citations

250

H-Index

Active since

2009

Affiliations

Research Triangle Park Foundation(Current)

R. Singh is an author at Research Triangle Park Foundation specializing in pharmacology, molecular oncology, and pharmacodynamics of anticancer agents.

Publications per year

2009–2016

Publications

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors

Jean‐Charles Soria, Hui Gan, Sarah P. Blagden et al. · Annals of Oncology · 2016 · 145 citations · Full text

Medicine, Oncology, Pharmacology +14

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

Juneko E. Grilley‐Olson, Philippe L. Bédard, Angelica Fasolo et al. · Investigational New Drugs · 2016 · 80 citations · Full text

Medicine, Oncology, Pharmacology +15

Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: A promising trioxane antimalarial in monkey plasma

R. Singh, Sreedharan Sabarinath, Nagsen Gautam et al. · Journal of Chromatography B · 2009 · 14 citations

Life Sciences, Medicinal Chemistry, Pharmacology +15

Dengue fever with rectus sheath hematoma: A case report

Anurag Sharma, Sonia Bhatia, R. Singh et al. · Journal of Family Medicine and Primary Care · 2014 · 11 citations · Full text

Veterinary Medicine, Infectious Diseases, Surgery +9

1–4 of 4